Patents by Inventor Anne-Christine Carlsson

Anne-Christine Carlsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biological materials and uses thereof
    Patent number: 8758749
    Abstract: The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: June 24, 2014
    Assignee: BioInvent International AB
    Inventors: Bjorn Frendéus, Anne-Christine Carlsson
  • BIOLOGICAL MATERIALS AND USES THEREOF
    Publication number: 20110262461
    Abstract: The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof.
    Type: Application
    Filed: March 22, 2011
    Publication date: October 27, 2011
    Inventors: Björn Frendéus, Roland Carlsson, Anne-Christine Carlsson
  • METHODS OF TREATMENT USING ANTI-OXIDIZED LDL ANTIBODIES
    Publication number: 20110256134
    Abstract: The present invention relates to methods and compositions for increasing insulin sensitivity comprising the administration of anti-oxidized LDL antibodies.
    Type: Application
    Filed: August 27, 2010
    Publication date: October 20, 2011
    Inventors: Stuart Bunting, Sherron Bullens, Roland Carlsson, Anne-Christine Carlsson, Björn Frendéus, Steven Glazer, Kevin Grove, Nick Van Bruggen
  • ICAM-1 binding antibodies
    Patent number: 7943744
    Abstract: The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: May 17, 2011
    Assignee: BioInvent International AB
    Inventors: Björn Frendéus, Roland Carlsson, Anne-Christine Carlsson, legal representative
  • IMMUNOTHERAPEUTIC TREATMENT
    Publication number: 20090208503
    Abstract: The use of immunotherapy against oxidised LDL to induce regression of pre-existing atherosclerotic lesions in an individual. The immunotherapy can be passive immunotherapy utilising antibodies that bind to epitopes present on oxidised LDL, or active immunotherapy utilising a vaccine composition for induction of an immune response against epitopes present on oxidised LDL.
    Type: Application
    Filed: September 4, 2006
    Publication date: August 20, 2009
    Applicant: BIOINVENT INTERNATIONAL AB
    Inventors: Roland Carlsson, Anne-Christine Carlsson, Jan Nilsson
  • BIOLOGICAL MATERIALS AND USES THEREOF
    Publication number: 20090087427
    Abstract: The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof.
    Type: Application
    Filed: December 8, 2006
    Publication date: April 2, 2009
    Inventors: Bjorn Frendeus, Roland Carlsson, Anne-Christine Carlsson